Skip to main content
VCbacked
Log inGet Started

Agitated Solutions

Saint Paul, United States

Agitated Solutions is a healthcare company that delivers microbubble treatment for patients with hypoxemic respiratory failure.

$3.8M raised
Oct 2025
Venture - Series Unknown
BiotechnologyHealth CareHealth DiagnosticsTherapeuticsWellness

Top Investors

Groove CapitalEngage Venture Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Agitated Solutions

How much funding has Agitated Solutions raised?
Agitated Solutions has raised $3.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
Who are Agitated Solutions's investors?
Agitated Solutions's investors include Groove Capital, Engage Venture Partners.
Where is Agitated Solutions headquartered?
Agitated Solutions is headquartered in Saint Paul, United States.
What does Agitated Solutions do?
Agitated Solutions is a healthcare company that delivers microbubble treatment for patients with hypoxemic respiratory failure.
What stage is Agitated Solutions at?
Agitated Solutions is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Agitated Solutions — Funding & Investors." VCBacked, October 22, 2025, https://www.vcbacked.co/company/agitated-solutions. Accessed June 3, 2026.
APA
VCBacked. (2025). Agitated Solutions — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/agitated-solutions
Wikipedia (cite web)
{{cite web |title=Agitated Solutions — Funding & Investors |url=https://www.vcbacked.co/company/agitated-solutions |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong